SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Digipath Inc (DIGP)

DIGP RSS Feed
Add DIGP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 12/5/2016 8:29:32 PM - Followers: 51 - Board type: Free - Posts Today: 0
For information see: http://digipath.com/

 


DigiPath’s team brings over 60 years combined expertise in pioneering digital pathology, implementing over 750 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.

 
Hardware

PathScope™

PathScope™ is a whole slide imaging system. PathScope™ provides high quality images in an open file format, which works with third party software packages. PathScope™ objectives can be configured with either 2, 4, 10, 20, 40, or 60x. Stage capacity options are 2, 4, or 200 slide trays.

Path Scope

PathLive™

PathLive™ is an affordable real time telepathology system. PathLive provides high quality images in a real time fashion and allows the remote user to remotely control objective magnifications, X & Y axis stage location, and Z axis focus plane. PathLive™ objectives can be configured with 4, 10, 20, and 40x objectives. Stage capacity is 2 slides.

Software

PathReview™

Since June 2011, DigiPath has provided PathReview™, as a web viewer and image server management system for whole digital slide images. PathReview™ supports files produced by DigiPath's PathScope™, and 5 other digital pathology systems. PathReview™ includes standard annotation, measurement, and conferencing capabilities. PathReview™ works with most common web browsers, without any plug-ins required.

PathConsult™

Since June 2011, DigiPath has provided PathConsult™, as end to end digital pathology solution to support remote consultation, 2nd opinions, and reporting capabilities. PathConsult™ provides workflows specifically for histotechnicians, pathologists, and administrators. DigiPath's PathScope™, and 5 leading digital pathology systems. PathConsults™ includes standard annotation, measurement, and conferencing capabilities. PathConsult™ works with most common web browsers, without any plug-ins required.

Solutions

PathCloud™

DigiPath’s team built telecom networks which supported over 35,000 locations throughout the country. DigiPath brings this IT experience to PathCloud™, the first and only telecom network optimized for digital pathology. PathCloud™ is an affordable, innovative, and reliable digital pathology solution networked engineered and optimized for highest digital pathology performance and reliability. PathCloud™ removes all your data storage and connectivity concerns..

PathTrade™

PathTrade™ is the exchange initiative that provides affordable and innovative digital pathology solutions, while also providing means for underserved communities to access pathology educational and medical experts throughout the world. PathTrade™ provides existing telepathology users an affordable means to upgrade discontinued telepathology systems with a DigiPath solution.

DigiPath will provide $500 to $5,000 as a trade-in credit for upgrading to PathScope and/or PathLive. Additionally, DigiPath will refurbish the used system, and deploy system without any additional fees, in communities in need of pathology educational and medical experts. DigiPath has identified many underserved communities in Africa, India, Middle East, Southeast Asia, Caribbean, and South America, for installation in 2012.

PathStore™

PathStore™ is a web based e-commerce vehicle for professional serives (consultations, 2nd opinions, & quality assurance) and third party software developers to market, sell, and implement their digital pathology solutions to PathScope™ users. PathStore™ includes the ability to place third party applications on the PathScope™ desktop, or in the connected PathCloud™ network. PathStore™ will be released worldwide in 2014.

PathGuarentee™

PathGuarentee™ is the digital pathology industry’s first MONEY BACK GUARANTEE program. Email info@digipath.biz for more details.




DigiPath develops and sells the affordable, innovative, and reliable digital pathology solutions for 2 nd opinion, consultation, tumor board, archiving, and educational purposes for improved workflow, analysis and data mining in support of pathology in academic medical centers, reference laboratories, biopharma organizations, and life science research institutions. Our digital pathology image-based information environment enabled by computer technology that allows for the management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed. Our digital pathology products, PathScope™, PathCloud™, PathReview™, and PathConsult™ provide a digital platform to share and store archive tissue images.

Digital Pathology Products Summary

DigiPath's digital pathology products are digital pathology solutions which employ the optical components of a standard microscope, robotic automated slide handling capabilities combined with proprietary imaging and communication software to capture high magnification images in digital format. These devices are comprised of both hardware and software.

DigiPath's digital pathology products, marketed under the names PathScope, PathCloud, PathReview, and PathConsult are used in hospital, educational pharmaceutical and research environments. Digital pathology solutions also include names of whole slide imaging and telepathology.

PathScope™ hardware

DigiPath’s PathScope is affordable, innovative, and reliable digital pathology solution. Depending on configuration, the pricing ranges from $25,000 to $75,000 capital purchase option. The options include capacity (1, 2, 3, 20, 30), objective (2.5x, 5x, 10x, 20x, 40x, 60x, 100x), barcode, and file format (JPEG, JP2k, TIFF). The reliability is based on 14 day validation period option, HIPPA, and 21CFR11 compliance.

PathCloud™ service

DigiPath's PathCloud is an affordable digital pathology solution networked engineered and optimized for digital pathology performance and reliability. PathCloud includes a USA national backbone network with 8 points of presence, 1000 TB storage, and 100M bandwidth, optimized for digital pathology. The reliability is based on PathCloud’s service level agreement which includes; 100% availability, 100% packet delivery, sub 200 milliseconds latency, and sub 1 second viewing time.

PathReview™ and PathConsult TM software

DigiPath's PathReview provides a scanner agnostic viewer and image server to review images via third party browsers, including Chrome, Internet Explorer, Firefox, and Safari. PathConsult has the features of PathReview with capability of doing a report and searchable database.

Advisory service(s)

DigiPath’s advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide. DigiPath provides advisory services for clients involved with digital pathology. Our current services range the full breadth of management operations for marketing, product development, sales outreach, operations, and customer support services. Our current clients seek our assistance in rolling out affordable, innovative, and reliable digital pathology solutions. Our potential clients include manufacturer (hardware and software), distribution and service firms, laboratories (reference, hospital owned, independent), private pathology practices (associated with hospitals), and centers of excellence.

Product Distribution

The Company sells its products either directly to end users, through exclusive distributors, non-exclusive distributors, and OEM (third party brands) depending on the application and the geographical location of the customer. Generally, qualified distributors and OEM are already in the business of selling bright field microscopes, equipment for medical analysis, or other laboratory equipment. Under the terms of the Company’s standard distribution agreements, distributors and OEM partners are assigned exclusive or non-exclusive territories or markets and, in turn, commit to purchasing a minimum amount of DigiPath products on either a quarterly or monthly basis.



Competitive Conditions



The digital pathology market is highly competitive, and many of our competitors have greater resources and better name recognition than we do. We primarily compete on affordability, innovation, and reliability. Our competitors in the digital pathology market include, Aperio, Apollo Telemedicine, D-Metrix, Hamamatsu, Nikon, Olympus, Carl Zeiss, OMNYX (owned by GE and UPMC), Leica (owned by Danaher), Phillips, Sakura, Roche, Claro, and MikroScan.

For advisory services, there are other firms providing such advisory services in the digital pathology space. There is currently an abundant need for such advisory services and we have not seen this as inhibiting our ability to garner new clients. Additionally, on larger engagements, we currently work with other advisory service firms which may be deemed as competitors. Some firms which we identified as clients may provide competitive services.

Industry



Digital pathology is the process of creating virtual slides by building digital images of physical tissue samples. Digital pathology allows drug developers, pathologists and researchers to be view tissue images through a computer or over a standard Internet connection and can be stored for later interpretation and archiving; and data mining in support of computer aided quantitative histopathology. The digital pathology markets can be categorized by type of tissue (human or animal) and use (clinical or research).

Digital pathology may improve patient care with a faster diagnosis time, more accurate diagnosis, more reproducible diagnosis, and probable lower medical costs. The improvement areas are a result of digital pathology means to provide faster turnaround time, faster access to sub-specialist, fast access to 2nd opinion, and more cost effective medical diagnosis’s.

Digital pathology is rapidly gaining momentum by reduce laboratory expenses, improve operational efficiency, enhance productivity, and improve treatment decisions and patient care. It is used worldwide in drug development, reference lab, hospital, and academic medical center settings. Applications include education, research, image analysis, archival and retrieval, laboratory information system (“LIS”) integration, secondary consultations, and virtual slide sharing. Today, education and training is the most common use for labs using digital pathology. The biggest barrier to more clinical use is the cost of scanning digital slides, which does not eliminate the need to first prepare glass slides.

Human Pathology

We estimate a total of 16,500 pathologists in the United States, with approximately two-thirds or 11,000 practicing anatomic pathology. These pathologists generally practice within one or more market segments, including hospital based pathology labs, integrated health systems, and commercial and academic research.

Pathologists focusing on human disease study the origin, course and indicators of disease. Pathology divides into clinical pathology the analysis of fluids such as urine and blood and DigiPath's market, anatomic pathology the analysis of tissue. Clinical pathology market is dominated by large national laboratories that use large-scale automation and is generally a high volume, low margin business. The technology for the automation of anatomic pathology has lagged that of clinical pathology. As a result, anatomic pathology remains a less consolidated and higher margin industry.

Animal (Veterinary) Pathology

Animal pathology includes testing in research and clinical treatment of both pets and livestock. Animal pathology for treatment is mainly conducted by labs providing services to veterinary practices. The majority of animal pathology is conducted by pharmaceutical and biotechnology companies for drug development.

The dynamics of veterinary pathology for treatment resemble human clinical pathology. Veterinary pathologists seek to improve access to clinical specialists: and aim to improve management and archiving of data workflow and tissue analysis.

The key market segments in animal pathology are pharmaceutical toxicology groups, academic and government research, contract research organizations (“CROs”), and biotechnology firms.

Digital Pathology Applications

Digital pathology products share common uses in both human and animal pathology, including consultation, communication and collaboration, education and publication, archiving and management, workflow, and analysis, as described below.

Consultation, Communication and Collaboration

Pathologists frequently consult with other pathologists and specialists in carrying out their daily work. There are often delays in consulting due to the transportation of slides or having to travel to distant locations in order to meet face-to-face. DigiPath's products allow sharing of images real time, eliminating the need for slide transportation or travel. Pathologists and specialists are able to simultaneously view and manipulate the slides and provide consultation in real-time. In addition, communication is improved as multiple pathologists and specialists can view and manipulate the same slide simultaneously.
- 4 -
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DIGP
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#545   Will not be in tomorrow but would love StevenRisk 12/05/16 08:29:32 PM
#544   On the call from Digipath will be Joe Magnum7419 12/05/16 04:11:45 PM
#543   The dial-in numbers for the corporate update call Magnum7419 12/05/16 04:10:51 PM
#542   You asked for it.......... Magnum7419 12/05/16 04:09:20 PM
#541   "The testing market in the United States is Magnum7419 12/01/16 03:27:40 PM
#540   "DigiPath, Inc. (OTCQB:DIGP): Magnum7419 12/01/16 08:04:16 AM
#539   No volume No interest! Come on management give StevenRisk 11/30/16 06:21:14 PM
#538   This sucks but definitely not a game stopper. StevenRisk 11/28/16 09:52:00 PM
#537   I just learned that the State of Colorado Magnum7419 11/28/16 08:59:40 PM
#536   I think both companies that ended their year Magnum7419 11/28/16 06:09:31 PM
#535   You have done a very good job bringing StevenRisk 11/28/16 05:31:37 PM
#534   Still digging found an address in colorado Magnum7419 11/27/16 08:29:27 PM
#533   Now I am confused....they have a website called Magnum7419 11/27/16 08:09:13 PM
#532   Plenty of time to load here in the StevenRisk 11/27/16 08:07:29 PM
#531   http://digipathlabscolorado.com/ Why they dont talk about Magnum7419 11/27/16 07:50:03 PM
#530   I looked all over but can only confirm StevenRisk 11/27/16 07:10:59 PM
#529   Pretty convinced this could be the real deal. StevenRisk 11/27/16 03:55:15 PM
#528   I think all we will to work with Magnum7419 11/27/16 03:37:02 PM
#527   As I have stated almost $800k was stock StevenRisk 11/27/16 03:34:55 PM
#526   Operating Loss Magnum7419 11/27/16 03:21:30 PM
#525   Convertible Preferred Stock Magnum7419 11/27/16 03:16:27 PM
#524   Just copying some highlites from last filing Magnum7419 11/27/16 03:15:31 PM
#523   Sorry I have not had time due to Magnum7419 11/27/16 02:53:42 PM
#522   Took a starter for 30k on Friday total. StevenRisk 11/27/16 02:11:37 PM
#521   "DigiPath Labs is setting the industry standard for Magnum7419 11/27/16 09:05:31 AM
#520   My biggest concern here is stock based compensation. StevenRisk 11/24/16 09:30:35 PM
#519   $DIGP Daily Chart $Pistol Pete$ 11/23/16 04:52:48 PM
#518   Well done.........call me crazy but all the DD Magnum7419 11/23/16 04:08:15 PM
#517   That buying was me except the last trade. StevenRisk 11/23/16 04:05:46 PM
#516   So if VVG grows 5,000 pounds and each Magnum7419 11/23/16 04:02:35 PM
#515   excellent....my guess is this upcoming quarter/end of year Magnum7419 11/23/16 03:21:05 PM
#514   Just got a starter of 10k for .19 StevenRisk 11/23/16 03:18:29 PM
#513   Been digging into DIGP and found they have Magnum7419 11/23/16 03:06:23 PM
#512   Here is a link of an overview of DIGP Magnum7419 11/23/16 02:29:33 PM
#511   DigiPath Labs to Open in Denver Magnum7419 11/23/16 02:21:38 PM
#510   Connect these dots : DIGIPATH... VVG ... Bhang.....= $$$$ Magnum7419 11/22/16 11:14:52 AM
#509   CDEL on top of bid and ask.......... short Magnum7419 11/22/16 09:57:39 AM
#508   $DIGP Bullish jjr04001 11/21/16 11:02:50 PM
#507   Been scaling out of CSA$ and may grab StevenRisk 11/21/16 10:19:56 PM
#506   I love to gamble but this one is Magnum7419 11/21/16 10:12:59 PM
#505   Hope you got out above $4 as it StevenRisk 11/21/16 10:04:55 PM
#504   Moved profit from packaging company to DIGP. It Magnum7419 11/21/16 03:57:59 PM
#503   more good news IMHO Magnum7419 11/21/16 11:51:29 AM
#502   I have contacted the company via email suggesting Magnum7419 11/18/16 12:40:19 PM
#501   Your welcome, your question happened to have been Magnum7419 11/18/16 09:29:02 AM
#500   Thanks for heads up, putting eye on this one! JohnBlaze 11/18/16 09:25:37 AM
#499   It appears DIGP has signed several growers since Magnum7419 11/18/16 08:54:09 AM
#498   DIGP has clients in both north and south Magnum7419 11/18/16 08:46:20 AM
#497   DIGP and VVG clients/growers in Nevada is Magnum7419 11/18/16 08:39:38 AM
#496   Just remember folks that IMHO Magnum7419 11/18/16 07:57:10 AM
PostSubject